Viens, P <br/><br/>
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial).  [electronic resource] 

 -  British journal of cancer  Oct 1999 
 - 449-56 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6690714  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Blood Transfusion<br/>Bone Marrow Diseases--chemically induced<br/>Breast Neoplasms--drug therapy<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Female<br/>Filgrastim<br/>Fluorouracil--administration & dosage<br/>Granulocyte Colony-Stimulating Factor--adverse effects<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Life Tables<br/>Mastectomy<br/>Middle Aged<br/>Radiotherapy, Adjuvant<br/>Recombinant Proteins<br/>Remission Induction<br/>Survival Rate